Accelerated lung function decline in an aluminium manufacturing industry cohort exposed to PM


Journal

Occupational and environmental medicine
ISSN: 1470-7926
Titre abrégé: Occup Environ Med
Pays: England
ID NLM: 9422759

Informations de publication

Date de publication:
12 2019
Historique:
received: 22 04 2019
revised: 04 09 2019
accepted: 25 09 2019
pubmed: 17 10 2019
medline: 10 3 2020
entrez: 17 10 2019
Statut: ppublish

Résumé

Occupational dust exposure has been associated with accelerated lung function decline, which in turn is associated with overall morbidity and mortality. In the current study, we assess potential benefits on lung function of hypothetical interventions that would reduce occupational exposure to fine particulate matter (PM Analyses were performed in a cohort of 6485 hourly male workers in an aluminium manufacturing company in the USA, followed between 1996 and 2013. We used the parametric g-formula to assess lung function decline over time under hypothetical interventions while also addressing time-varying confounding by underlying health status, using a composite risk score based on health insurance claims. A counterfactual scenario envisioning a limit on exposure equivalent to the 10th percentile of the observed exposure distribution of 0.05 mg/m Our results indicate that occupational PM

Identifiants

pubmed: 31615860
pii: oemed-2019-105908
doi: 10.1136/oemed-2019-105908
pmc: PMC7771835
mid: NIHMS1655789
doi:

Substances chimiques

Dust 0
Particulate Matter 0
Aluminum CPD4NFA903

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

888-894

Subventions

Organisme : NIA NIH HHS
ID : R01 AG026291
Pays : United States
Organisme : NIOSH CDC HHS
ID : R01 OH009939
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: KH has received compensation as a member of the scientific advisory board for Alcoa, Inc. (Pittsburgh, Pennsylvania) and for consulting for Alcoa, Inc. in the past. MRC has received salary support from Alcoa, Inc. through contracts with Stanford University (Stanford, California).

Références

Occup Environ Med. 2010 Oct;67(10):679-85
pubmed: 20798006
Am J Ind Med. 2015 Jan;58(1):14-20
pubmed: 25384732
Scand J Work Environ Health. 2014 Jan;40(1):19-35
pubmed: 24220056
PLoS One. 2015 May 07;10(5):e0126054
pubmed: 25951622
Int J Occup Environ Health. 1997 Jan;3(1):13-19
pubmed: 9891096
Am J Ind Med. 2016 Apr;59(4):322-9
pubmed: 26853811
Am J Ind Med. 2011 Mar;54(3):224-31
pubmed: 21298697
Occup Environ Med. 2011 Jan;68(1):24-9
pubmed: 20798007
Thorax. 1984 Oct;39(10):743-51
pubmed: 6495242
Am J Respir Crit Care Med. 2010 Jun 1;181(11):1162-3
pubmed: 20535848
J Occup Environ Med. 2007 Nov;49(11):1269-87
pubmed: 17993932
Thorax. 2018 Nov;73(11):1008-1015
pubmed: 29574416
BMJ. 1996 Sep 21;313(7059):711-5; discussion 715-6
pubmed: 8819439
Int J Epidemiol. 1995 Dec;24(6):1154-61
pubmed: 8824857
Thorax. 2009 Jan;64(1):6-12
pubmed: 18678700
Am J Respir Crit Care Med. 2010 Jun 1;181(11):1234-40
pubmed: 20203247
Chest. 2002 Jun;121(6):2052-60
pubmed: 12065377
Am J Epidemiol. 2014 Sep 15;180(6):608-15
pubmed: 25125691
Scand J Work Environ Health. 2017 Nov 1;43(6):595-603
pubmed: 28782791
Am J Respir Crit Care Med. 2009 Aug 1;180(3):257-64
pubmed: 19423717
Scand J Work Environ Health. 2018 Sep 1;44(5):547-554
pubmed: 29870045
Am J Respir Crit Care Med. 2010 Sep 1;182(5):693-718
pubmed: 20802169
N Engl J Med. 2015 Jul 9;373(2):111-22
pubmed: 26154786
Am J Respir Crit Care Med. 1999 Jan;159(1):179-87
pubmed: 9872837
J Occup Environ Med. 2007 Sep;49(9):1020-6
pubmed: 17848858
J Expo Sci Environ Epidemiol. 2014 Jan-Feb;24(1):89-99
pubmed: 24022670
Int J Epidemiol. 2009 Dec;38(6):1599-611
pubmed: 19389875
Am J Respir Crit Care Med. 1995 Sep;152(3):1107-36
pubmed: 7663792
Lung. 2013 Jun;191(3):257-63
pubmed: 23568145
Occup Environ Med. 2004 Jul;61(7):604-8
pubmed: 15208376
Int J Epidemiol. 2019 Oct 1;48(5):1412-1422j
pubmed: 31220278
Am J Respir Crit Care Med. 2003 Mar 1;167(5):787-97
pubmed: 12598220
Am J Respir Crit Care Med. 2006 May 1;173(9):985-90
pubmed: 16439715

Auteurs

Andreas M Neophytou (AM)

Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, Colorado, USA andreas.neophytou@colostate.edu.
School of Public Health, Division of Environmental Health Sciences, University of California Berkeley, Berkeley, California, USA.

Sadie Costello (S)

School of Public Health, Division of Environmental Health Sciences, University of California Berkeley, Berkeley, California, USA.

Sally Picciotto (S)

School of Public Health, Division of Environmental Health Sciences, University of California Berkeley, Berkeley, California, USA.

Elizabeth M Noth (EM)

School of Public Health, Division of Environmental Health Sciences, University of California Berkeley, Berkeley, California, USA.

Sa Liu (S)

School of Public Health, Division of Environmental Health Sciences, University of California Berkeley, Berkeley, California, USA.
School of Health Sciences, Purdue University, West Lafayette, Indiana, USA.

Liza Lutzker (L)

School of Public Health, Division of Environmental Health Sciences, University of California Berkeley, Berkeley, California, USA.

John R Balmes (JR)

School of Public Health, Division of Environmental Health Sciences, University of California Berkeley, Berkeley, California, USA.

Katharine Hammond (K)

School of Public Health, Division of Environmental Health Sciences, University of California Berkeley, Berkeley, California, USA.

Mark R Cullen (MR)

Department of Internal Medicine, Stanford University School of Medicine, Stanford, California, USA.

Ellen A Eisen (EA)

School of Public Health, Division of Environmental Health Sciences, University of California Berkeley, Berkeley, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH